Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin [aapp, bacs, phsu]
receptor [aapp, rcpt]
Primary hypertension [dsyn]
Background [cnce]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
prescribed [hlca]
Primary hypertension [dsyn]
Systolic blood pressure [clna]
mmHg [qnco]
Diastolic blood pressure [clna]
mmHg [qnco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Show [inpr]
To [qlco]
Mortality [qnco]
Morbidity [qnco]
placebo-controlled [resa]
Trial [resa]
Angiotensin Receptor Blockers [phsu]
Not [ftcn]
Comparison [acty]
Efficacy [qlco]
Two [qnco]
Drug [phsu]
Class [inpr]
Primary hypertension [dsyn]
PREVENT [phsu]
Mortality [qnco]
cardiovascular events [fndg]
objectives [inpr]
To [qlco]
Compare [acty]
effects [qlco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Mortality [qnco]
cardiovascular events [fndg]
Rate [acty]
Of [spco]
Withdrawal [acty]
Due to [ftcn]
adverse effects [ftcn]
People [popg]
Primary hypertension [dsyn]
search [inpr]
Methods [inpr]
Searched [acty]
Hypertension [dsyn]
Group [idcn]
specialized [qlco]
Central [spco]
Controlled [ftcn]
Trial [resa]
MEDLINE [inpr]
World Health Organization [hcro]
International [idcn]
Clinical Trials [resa]
Registry [inpr]
Platform [resd]
Web [mnob]
Science [ocdi]
contact [ftcn]
Study Author [prog]
Missing [idcn]
Information [idcn]
Searched [acty]
Reference [idcn]
List [cnce]
Relevant [qlco]
reviews [inpr]
eligible [idcn]
studies [lbpr]
Selection Criteria [qlco]
included [ftcn]
randomized controlled trials [inpr, resa]
People [popg]
Uncontrolled [qlco]
Controlled [ftcn]
Primary hypertension [dsyn]
risk factors [qnco]
included [ftcn]
Trial [resa]
Compared [acty]
Angiotensin-converting enzyme inhibitor [phsu]
Head [blor]
Last [qlco]
Duration [tmco]
One [qnco]
If [qlco]
Background [cnce]
Blood Pressure [orgf]
lowering [spco]
Agent [chvf]
Continued [idcn]
Added [ftcn]
Study [mnob]
Protocol [inpr]
Same [qlco]
Study [mnob]
ARMS [neop]
Data Collection [resa]
Analysis [lbpr]
Standard [qlco]
methodology [inpr]
procedures [inpr]
Expected [idcn]
Collaboration [socb]
Main [qlco]
Result [ftcn]
Nine [qnco]
studies [lbpr]
participants [popg]
included [ftcn]
included [ftcn]
studies [lbpr]
Five [qnco]
report data [resa]
Mortality [qnco]
Three [qnco]
report data [resa]
cardiovascular events [fndg]
Four [qnco]
report data [resa]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
Study [mnob]
Reported [inpr]
Cardiovascular morbidity [dsyn]
Contrast [qlco]
Eight [qnco]
Study [mnob]
Contribute [acty]
Data [idcn]
included [ftcn]
studies [lbpr]
Good [qlco]
Moderate [qlco]
Quality [qlco]
Evidence [ftcn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Mortality [qnco]
Risk Ratio [qnco]
Confidence Interval [qnco]
cardiovascular events [fndg]
Risk Ratio [qnco]
Confidence Interval [qnco]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
Risk Ratio [qnco]
Confidence Interval [qnco]
High [qlco]
Level [qlco]
Evidence [ftcn]
Indicated [fndg]
Slightly [idcn]
Lower [spco]
Incidence [qnco]
Angiotensin Receptor Blockers [phsu]
Compared [acty]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Risk Ratio [qnco]
Confidence Interval [qnco]
Absolute Risk Reduction [qnco]
Needed [qlco]
To [qlco]
TREAT [ftcn]
Additional [ftcn]
Outcome [ftcn]
Attributable [menp]
High [qlco]
Incidence [qnco]
Dry cough [sosy]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Quality [qlco]
Evidence [ftcn]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
Limited [ftcn]
Possible [qlco]
Publication Bias [qlco]
Several [qnco]
studies [lbpr]
Initially [tmco]
eligible [idcn]
Inclusion [qlco]
Review [inpr]
Data [idcn]
Available [ftcn]
Hypertension [dsyn]
subgroup [virs]
End [spco]
Evidence [ftcn]
Mortality [qnco]
Judge [prog]
To [qlco]
Moderate [qlco]
Evidence [ftcn]
cardiovascular events [fndg]
Judge [prog]
To [qlco]
low [qlco]
Grade [clas]
Approach [spco]
Authors [prog]
Conclusions [idcn]
Analysis [lbpr]
Found [qnco]
Evidence [ftcn]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
Angiotensin Receptor Blockers [phsu]
Compared [acty]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Slightly [idcn]
Withdrawal [acty]
Due to [ftcn]
adverse effects [ftcn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Show [inpr]
Efficacy [qlco]
Outcome [ftcn]
placebo [topp]
Result [ftcn]
To [qlco]
Same [qlco]
Conclusion [idcn]
Angiotensin Receptor Blockers [phsu]
Directly [qlco]
Not [ftcn]
Study [mnob]
placebo-controlled [resa]
Trial [resa]
Hypertension [dsyn]
Substitution [idcn]
Angiotensin-converting enzyme inhibitor [phsu]
Supported [cnce]
Evidence [ftcn]
TOLERABILITY [resa]
Make [ftcn]
consideration [fndg]
Weak [sosy]
Evidence [ftcn]
Efficacy [qlco]
Angiotensin Receptor Blockers [phsu]
Mortality [qnco]
Morbidity [qnco]
Outcome [ftcn]
Compared [acty]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Data [idcn]
participants [popg]
Exist [cnce]
Clinical [qlco]
sequelae [patf]
Hypertension [dsyn]
Data [idcn]
Asymptomatic [fndg]
People [popg]
Increase [ftcn]
Review [inpr]
subgroup [virs]
Data [idcn]
hypertensive [fndg]
participants [popg]
Trial [resa]
Compare [acty]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Need [qlco]
To [qlco]
Make [ftcn]
Available [ftcn]
Purpose [ftcn]
